AUPH
Aurinia Pharmaceuticals Inc.Company with tickers: AUPH
CIK
1600620
CUSIP
05156V102
Shares Outstanding
128,601,671
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $77,705,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Cost of Revenue | $6,505,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $7,470,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $41,422,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Net Income | $34,355,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $0.26 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $0.25 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |